SLP
Overvalued by 24.6% based on the discounted cash flow analysis.
Market cap | $1.00 Billion |
---|---|
Enterprise Value | $894.84 Million |
Dividend Yield | $0.2389 (0.48%) |
Earnings per Share | $0.52 |
Beta | 1.02 |
Outstanding Shares | 19,984,945 |
Avg 30 Day Volume | 83,366 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 95.41 |
---|---|
PEG | -2746.53 |
Price to Sales | 16.98 |
Price to Book Ratio | 6.37 |
Enterprise Value to Revenue | 13.84 |
Enterprise Value to EBIT | 97.11 |
Enterprise Value to Net Income | 85 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...